Sale of Product Line - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Jun. 30, 2025	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of product line				$ 488	$ 5,366
Gain on sale of product line					$ 7,580
Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of product line	$ 5,000
Transaction | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Amount minimum revenue share payments receivable	3,000		$ 3,000
Amount minimum revenue share payments receivable current		$ 1,300		1,300
Amount minimum revenue share payments receivable non-current		1,100		1,100
Variable Consideration		$ 0		0
Transaction | Minimum | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue sharing payments	3,000		3,000
Variable consideration	3,000		3,000
Transaction | Maximum | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue sharing payments	7,000		7,000
Variable consideration	7,000		7,000
Transaction | Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net carrying value	800		800
Carrying value	0		0
Consideration received for inventory on-hand	400
Consideration determined	$ 8,400		8,400
Gain on sale of product line			$ 7,600
Revenue share payments collected				$ 600